Article Text

Download PDFPDF

410 Endometrial cancer in young women: epidemiological features, therapeutic characteristics and prognosis
  1. O Kaabia,
  2. G Nourallah,
  3. Z Rym,
  4. L Aymen,
  5. S Aymen,
  6. B Mohamed and
  7. K Hédi
  1. Université de Sousse- Faculté de Médecine de Sousse- Hopital Farhat Hached- LR12ES03- 4000- Sousse- Tunisia-, Gynecology and obstetrics department- Farhat Hached Teaching Hospital, sousse, Tunisia


Objectives The purpose of this study was to evaluate the epidemic profile and the survival rate of endometrial carcinoma in women ≤45 years of age in Tunisia

Methods It is a retrospective study of a prospective mono-centric database from January 2008 to January 2019. We evaluated the clinical history, treatment, and follow-up of 20 women ≤45 years of age diagnosed with endometrial cancer, from a global cohort of 228 patients diagnosed in our center with endometrial cancer during the same period.

Results The mean age was 40 years (29–45). Fifteen patients (75%) were married at the time of diagnosis and 12 (60%) were nulliparous. Menorragia was the main revealing symptom (60%). According to the FIGO classification for endometrial cancer: IA, 9 (45%); IB, 4 (20%). Tumors were well differentiated in 6 (30%), moderately differentiated in 5 (25%), and poorly differentiated in 9 (45%).A fertility-sparing technique was proposed in 9 cases (45%) and only one patient did not have hysterectomy. All patients had laparotomy when surgery was performed. External Radiotherapy was indicated in 25% of the patients and curitherapy in 10%.35% of the patients had chemotherapy. The mean overall survival (OS) was 104 months ±10. The OS and the disease free survival (DFS) at 3 and 5 years were equal, respectively at 95% and 80%.

Conclusions Patients ≤45 years of age with endometrial cancer represent less than 10% of all endometrial cancer patients. Although, advanced stage disease is prevalent (45%), the prognosis at 5 years seems acceptable (OS and DFS 80%).

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.